Cannabis Stocks You Should Know- THC Therapeutics, Inc. (THCT)
June 03 2019 - 9:15AM
InvestorsHub NewsWire
Cannabis stocks have dipped with the broader market making now
an ideal time to start researching some gems you may have
missed.
Las Vegas, NV -- June 3, 2019 -- InvestorsHub NewsWire --
via Regal
Consulting
That’s why we’re highlighting THC Therapeutics, Inc.
(THCT).
THCT also recently differentiated itself when it announced the
appointment of Enzo Villani to the company’s Board of
Directors. Mr. Villani has raised over $500 million in
funding from strategic investors, private equity, venture capital,
family offices and the public markets during his over twenty-year
career.
THCT’s dHydronator® can reduce moisture content of
cannabis to 10% in only 10-14 hours. This is the
same reason Aurora just signed $10M deal with EnWave. THCT
received patent protection on 20 claims from the US patent office
and will be using their patented designs to carve out their piece
of the legal cannabis market expected to reach $146.4 billion by
2025.
Today we are highlighting: THC Therapeutics, Inc.
(THCT),
Cronos Group Inc. (CRON),
MedMen Enterprises Inc. (MMNFF),
The Green Organic Dutchman Holdings Ltd. (TGODF),
and MariMed Inc. (MRMD).
THC Therapeutics, Inc. (THCT)
(Market Cap: $99.839M; Share Price: $7.25) has
developed a sanitizing herb dryer, The dHydronator®. Their
laboratory-proven product is specifically designed for drying and
sanitizing freshly harvested cannabis and herbs.
THCT’s product has been tested by two independent
laboratories. The testing covered over 6 strains and 9
independent tests to confirm the findings. Over the 9 tests
and 6 strains, there was a 4% average increase of
THC-A*.
The US patent office has accepted ALL 20 claims for the
dHydronator®. The company has received full patent
protection for the dHydronator®; this is big. Start your
research today on THCT.
________
Cronos Group Inc. (CRON)
(Market Cap: $4.781B; Share Price:
$14.08) announced a multi-year supply agreement with
MediPharm Labs Corp. MediPharm Labs will supply Cronos with
private label cannabis concentrate over an 18-to-24-month
period. This agreement will provide Cronos Group with
specialized extraction capabilities and expertise to serve growing
consumer and market demand. Cronos Group is a global
cannabinoid company with international production and distribution
focused on advancing cannabis research, technology and product
development.
________
MedMen Enterprises Inc. (MMNFF)
(Market Cap: $368.585M; Share Price: $2.19)
released news that they have been advanced an additional US $80M in
gross proceeds following the secured $250M convertible credit
facility with Gotham Green Partners, investors in the global
cannabis industry. MedMen is a cannabis retailer with
operations across the U.S., including flagship stores in Los
Angeles, Las Vega,s and New York.
________
The Green Organic Dutchman Holdings Ltd. (TGODF)
(Market Cap: $702.479M; Share Price: $2.602)
announced that it has secured a cannabis supply agreement with
Alberta Gaming, Liquor & Cannabis. By partnering in this
agreement, TGODF plans to expand its Western Canadian
footprint. TGODF is a large Canadian producer of organic
cannabis flowers and oils.
________
MariMed Inc. (MRMD)
(Market Cap: $599.634M; Share Price: $2.82)
reported 1st-quarter results ending March 31, 2019, indicating
revenue growth and improved operating performance as compared to
2018. Results are attributed to operational improvements
under company management. MariMed, Inc. offers a range of
cannabis products with a separate division focused on industrial
hemp-derived CBD products.
Legal Disclaimer:
This article was written by Regal Consulting, LLC (“Regal
Consulting”). Regal Consulting has agreed to a three-month
term consulting agreement with THCT dated 2/14/18. The
agreement calls for 50,000 restricted shares of THCT per month.
This agreement has been amended to $20,000 per month, and 55,000
shares per month and extended for twelve months ending
3/18/2020. All payments were made directly by THC
Therapeutics, Inc. to Regal Consulting, LLC. to provide investor
relations services, of which this article is a part of. Regal
Consulting also paid one thousand dollars cash to
microcapspeculators.com to distribute this article. Regal
Consulting may have a position in the securities mentioned in this
article at the time of publication, and may increase or decrease
its position without notice. This article is based on public
information and the opinions of Regal Consulting. THCT was given an
opportunity to edit this article. This article contains
forward-looking statements that are subject to certain risks and
uncertainties that could cause actual results to differ materially
from any results predicted herein. Regal Consulting is not
registered with any financial or securities regulatory authority,
and does not provide or claim to provide investment advice.
http://www.regalconsultingllc.com/full
legal disclaimer/
Full Legal Disclaimer Click Here.
Contact Information:
Company Name: ACR Communication LLC.
Contact Person: Media Manager
Email: info@microcapspeculators.com
Phone: 1-702-720-6310
Country: United States
THC Therapeutics (CE) (USOTC:THCT)
Historical Stock Chart
From Oct 2024 to Nov 2024
THC Therapeutics (CE) (USOTC:THCT)
Historical Stock Chart
From Nov 2023 to Nov 2024
